REFERENCES
  1. Sakai K , Maruyama-Maebashi K , Takatsu A , et al . Sudden death involving inhalation of 1,1-difluoroethane (HFC-152a) with spray cleaner: Three case reports . Forensic Sci. Int 2011 ; 206 : e58 – e61 .
  2. Williams DR, Cole SJ. Ventricular fibrillation following butane gas inhalation. Resuscitation. 1998;37(1):43-5
  3. Brady WJ, Stremski E, et al. Freon inhalational abuse presenting with ventricular fibrillation. Am J Emerg Med 1994;12(5): 533-536.
  4. Tormoehlen LM, Tekulve KJ, Nañagas KA. Hydrocarbon toxicity: A review, Clinical Toxicology, 2014;52:5, 479-489.
  5. Waters EM, Gerstner HB, Huff JE. Trichloroethylene. I. An overview. J Toxicol Environ Health. 1977;2(3):671-707.
  6. Himmel HM. Mechanisms Involved in Cardiac Sensitization by Volatile Anesthetics: General Applicability to Halogenated Hydrocarbons? Critical Reviews in Toxicology 2008;38:773–803.
  7. Scholz, E.P., Alter, M., Zitron, E., et al. In-vitro modulation of hERG channels by organochlorine solvent trichloromethane as potential explanation for proarrhythmic effects of chloroform. Toxicol. Lett. 20026;165:156–166.
  8. Shibata, S., Ono, K et al, T. Sevoflurane inhibition of the slowly activating delayed rectifier K+ current in guinea-pig ventricular cells. J. Pharmacol. Sci. 2004;95:363–373.
  9. Fleckenstein, A. E., Volz, T. J., Riddle, et al.. New insights into the mechanism of action of amphetamines. Annual Review of Pharmacology and Toxicology 2007;47, 681–698.
  10. Carvalho, M., Carmo, H., Costa, V. M., Capela, J. P., Pontes, H., Remiao, F, Bastos M. de L. Toxicity of amphetamines: an update. Archives of Toxicology 2012; 86(8), 1167–1231.
  11. Paratz ED, Cunningham NJ, MacIsaac AI. The Cardiac Complications of Methamphetamines. Heart, Lung and Circulation 2016:(25):325–332.
  12. Liang, R., Zhou, Y., Wu, F., Zhou, C., Zhao, X., Zhang, M. Effect of methamphetamine on potassium and L-type calcium currents in rat ventricular myocytes. Toxicology Mechanisms and Methods 2010;20(8), 458–465.
  13. Martinez-Raga J, Knecht C, Szerman N, Martinez MI. Risk of serious cardiovascular problems with medications for attention-deficit hyperactivity disorder. CNS Drugs. 2013;27(1):15-30.
  14. Credible Meds.QT drugs categorized by their potential to cause QT prolongation and/or torsades de pointes (TdP). Available at: https://crediblemeds.org/. Accessed on June 17 2020.
  15. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-45.